DFX Intelligence

Daniel Marvin Watkins

Role unknown· TX

As of 2026-09-12 · this person's identity; each section below carries its own date

Current roles: 0
Investments attributed: 8
Board seats: 4

Ask DFX about this View relationships Find contacts Investments Board seats

As of 2026-09-12 · this person's identity; each section below carries its own date

1 additional role or seat, 5 additional attributed investments

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Nothing material in the last 365 days. Last change: 4 Jun 2024, Latest AskY Therapeutics Form D equity offering ($460K) on 4 Jun 2024.

Relationship network

5 connected entities8 observed investment records4 dated investment records shown here, 2018 to 2024

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Some relationships on this record are counted rather than named here. They open with the full profile.

Daniel Marvin Watkins

1 more attributed investment on this record

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Reading the network

Organization
Company

›How strength and recency are read

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

Ask DFX about this network

Which companies and boards is Daniel Marvin Watkins connected to?

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Daniel Marvin Watkins: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Daniel Marvin Watkins

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

0 current, 1 past

Mercury Fund Managing Member
Mar 1, 2005 to Mar 23, 2023 · “Listed on Schedule A of filing 2022-03-25 as MANAGING MEMBER, absent from filing 2023-03-23”
Inference Form ADV

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
AskY Therapeutics, Inc.	Form D equity offering · $460,000	Mercury Fund	strongly supported · board	Jun 4, 2024	Inference sec.gov
Olea Networks, Inc.	Form D equity offering · $34.9M	Mercury Fund	strongly supported · board	Sep 29, 2021	Inference sec.gov
Olea Networks, Inc.	Form D equity offering · $9.0M	Mercury Fund	strongly supported · board	Feb 19, 2020	Inference sec.gov

Board seats and vehicles

4 boards, 0 vehicles

AskY Therapeutics, Inc. board seat on a deal Jun 4, 2024 Inference
Olea Networks, Inc. board seat on a deal Sep 29, 2021 Inference
Dnatrix Inc board seat on a deal Sep 25, 2018 Inference

Timeline

6 dated entries: events, attributed deals, board seats and role changes

Jun 4, 2024
Form D equity offering in AskY Therapeutics, Inc. (Mercury Fund)
Attributed investment Inference AskY Therapeutics, Inc. Form D
Mar 23, 2023
Daniel Marvin Watkins (Managing Member) no longer on Schedule A of Mercury Fund
Person left Inference Mercury Fund Form ADV
Mar 23, 2023
Left Mercury Fund as Managing Member
Role ended Inference Mercury Fund Form ADV
Sep 29, 2021
Form D equity offering in Olea Networks, Inc. (Mercury Fund)
Attributed investment Inference Olea Networks, Inc. Form D
Feb 19, 2020
Form D equity offering in Olea Networks, Inc. (Mercury Fund)
Attributed investment Inference Olea Networks, Inc. Form D

Full timeline · 6 entriesnewest first

Jun 4, 2024
Form D equity offering in AskY Therapeutics, Inc. (Mercury Fund)
Attributed investment Inference AskY Therapeutics, Inc. Form D
Mar 23, 2023
Daniel Marvin Watkins (Managing Member) no longer on Schedule A of Mercury Fund
Person left Inference Mercury Fund Form ADV
Mar 23, 2023
Left Mercury Fund as Managing Member
Role ended Inference Mercury Fund Form ADV
Sep 29, 2021
Form D equity offering in Olea Networks, Inc. (Mercury Fund)
Attributed investment Inference Olea Networks, Inc. Form D
Feb 19, 2020
Form D equity offering in Olea Networks, Inc. (Mercury Fund)
Attributed investment Inference Olea Networks, Inc. Form D
Mar 1, 2005
Joined Mercury Fund as Managing Member
Role began Inference Mercury Fund Form ADV

Record history

1 dated event on the change ledger, latest event first

Person left
2023-03-23source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.